Adaptive Biotechnologies Corporation (NASDAQ: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into clinical products to diagnose and ...

It's been a roller coaster of a legislative session in Florida this year. Republican-led lawmakers, who have for years been ...

Following positive opinion, Carthera is one of the first companies to benefit from brand-new status – intended to support early access pathways for innovative devices targeting rare diseasesParis, ...

FDA decision will enable Iksuda to expand its ongoing clinical trial in the US, Australia and Singapore Preliminary data from an ongoing dose-escalation study of IKS014 has shown meaningful clinical ...

Report Metric Details Base year considered 2023 Forecast period considered 2024-2029 Base year market size $108.

LogicFlo AI, a startup optimizing regulatory and operational workflows for life sciences companies using artificial ...

BRISBANE, CA, USA I June 30, 2025 I Tempest Therapeutics, Inc. (Nasdaq: TPST), a clinical-stage biotechnology company with a pipeline of first-in-classi ...

BidMax ™, a pioneering AI-powered real estate transaction platform known for its flat-fee offering, announced today the ...